(Q53300849)

13 May 2018

title

Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. (English)

1 reference

13 May 2018

author name string

Shi-Lian Hu

1

1 reference

13 May 2018

Da-Bing Huang

2

1 reference

13 May 2018

Yu-Bei Sun

3

1 reference

13 May 2018

Lei Wu

4

1 reference

13 May 2018

Wei-Ping Xu

5

1 reference

13 May 2018

Shi Yin

6

1 reference

13 May 2018

Jiong Chen

7

1 reference

13 May 2018

Xiao-Dong Jiang

8

1 reference

13 May 2018

Gan Shen

9

1 reference

13 May 2018

publication date

19 March 2010

1 reference

13 May 2018

published in

Medical Oncology

1 reference

13 May 2018

volume

28

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

447-454

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-010-9467-6

exact match

0 references

cites work

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Epigenetic inactivation of CHFR in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Chfr defines a mitotic stress checkpoint that delays entry into metaphase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Spreading of methylation within RUNX3 CpG island in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

CpG island hypermethylation in progression of esophageal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Molecular biomarkers in urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9467-6

Cancer: new-age tumour suppressors

21 January 2018

1 reference

12 December 2020

Aberrant methylation of the CHFR gene in digestive tract cancer.

1 reference

12 December 2020

Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia

1 reference

12 December 2020

Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers

1 reference

12 December 2020

Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.

1 reference

12 December 2020

Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer

1 reference

12 December 2020

10.1007/S12032-010-9467-6

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

20300977

1 reference

13 May 2018